Free Trial Information
BioCentury | Feb 4, 2008
Company News

PolyMedix board of directors update

...PolyMedix Inc. (OTCBB:PYMX), Radnor, Penn. Business: Infectious Appointed: Brian Anderson, former president and CEO of Cognetix Inc. WIR...
Read More
BioCentury | Sep 5, 2005
Clinical News

CGX-1160 regulatory update

...broad spectrum non-opioid analgesic has completed a Phase Ib trial to treat chronic intractable pain. Cognetix Inc....
Read More
BioCentury | Jun 28, 2004
Company News

Prolexys Pharma management update

...Rogers as VP of business development, formerly VP of business development and strategic planning at Cognetix Inc. WIR...
Read More
BioCentury | Feb 23, 2004
Company News

PolyMedix management update

...regulatory affairs, formerly VP of regulatory affairs and quality assurance and chief regulatory officer at Cognetix Inc. WIR...
Read More
BioCentury | Aug 4, 2003
Company News

Alexza Molecular Delivery Corp. management update

...Thomas King as president, CEO and a director, formerly president, CEO and a director of Cognetix Inc. WIR...
Read More
BioCentury | Jul 29, 2003
Company News

Alexza hires King as CEO

...as president, CEO and a director. He was formerly president, CEO and a director at Cognetix...
Read More
BioCentury | Sep 23, 2002
Company News

Cognetix board of directors update

Cognetix Inc. , Salt Lake City, Utah Business: Neurological Appointed: Dennis Farrar, co-founder, as chairman; and Doreen Grech, principal at A.M. Pappas and Associates Resigned: Davis Temple WIR Staff Neurology...
Read More
BioCentury | Sep 23, 2002
Company News

Cognetix management update

Cognetix Inc. , Salt Lake City, Utah Business: Neurological Hired: Thomas King as president, CEO and a director, formerly president, CEO and director at Anesta Corp. , which was acquired by Cephalon Inc. Promoted: Carl Roland to...
Read More
BioCentury | Sep 17, 2002
Company News

Cognetix names King president, CEO

...previously president, CEO and a director at Anesta prior to its acquisition by Cephalon (CEPH). Cognetix...
Read More
BioCentury | Sep 16, 2002
Product Development

NMDA outlook

...5161 Blocker of the ion channel associated with the NMDA receptor Neuropathic pain Ph II Cognetix...
Read More
Items per page:
1 - 10 of 34
BioCentury | Feb 4, 2008
Company News

PolyMedix board of directors update

...PolyMedix Inc. (OTCBB:PYMX), Radnor, Penn. Business: Infectious Appointed: Brian Anderson, former president and CEO of Cognetix Inc. WIR...
Read More
BioCentury | Sep 5, 2005
Clinical News

CGX-1160 regulatory update

...broad spectrum non-opioid analgesic has completed a Phase Ib trial to treat chronic intractable pain. Cognetix Inc....
Read More
BioCentury | Jun 28, 2004
Company News

Prolexys Pharma management update

...Rogers as VP of business development, formerly VP of business development and strategic planning at Cognetix Inc. WIR...
Read More
BioCentury | Feb 23, 2004
Company News

PolyMedix management update

...regulatory affairs, formerly VP of regulatory affairs and quality assurance and chief regulatory officer at Cognetix Inc. WIR...
Read More
BioCentury | Aug 4, 2003
Company News

Alexza Molecular Delivery Corp. management update

...Thomas King as president, CEO and a director, formerly president, CEO and a director of Cognetix Inc. WIR...
Read More
BioCentury | Jul 29, 2003
Company News

Alexza hires King as CEO

...as president, CEO and a director. He was formerly president, CEO and a director at Cognetix...
Read More
BioCentury | Sep 23, 2002
Company News

Cognetix board of directors update

Cognetix Inc. , Salt Lake City, Utah Business: Neurological Appointed: Dennis Farrar, co-founder, as chairman; and Doreen Grech, principal at A.M. Pappas and Associates Resigned: Davis Temple WIR Staff Neurology...
Read More
BioCentury | Sep 23, 2002
Company News

Cognetix management update

Cognetix Inc. , Salt Lake City, Utah Business: Neurological Hired: Thomas King as president, CEO and a director, formerly president, CEO and director at Anesta Corp. , which was acquired by Cephalon Inc. Promoted: Carl Roland to...
Read More
BioCentury | Sep 17, 2002
Company News

Cognetix names King president, CEO

...previously president, CEO and a director at Anesta prior to its acquisition by Cephalon (CEPH). Cognetix...
Read More
BioCentury | Sep 16, 2002
Product Development

NMDA outlook

...5161 Blocker of the ion channel associated with the NMDA receptor Neuropathic pain Ph II Cognetix...
Read More
Items per page:
1 - 10 of 34